Introduction:Basic information about CAS 7487-88-9|magnesium sulfate, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | magnesium sulfate |
|---|
| CAS Number | 7487-88-9 | Molecular Weight | 120.368 |
|---|
| Density | 1.07 g/mL at 20 °C | Boiling Point | 330ºC at 760 mmHg |
|---|
| Molecular Formula | MgO4S | Melting Point | 1124 °C |
|---|
| MSDS | USA | Flash Point | / |
|---|
Names
| Name | magnesium sulfate |
|---|
| Synonym | More Synonyms |
|---|
magnesium sulfate BiologicalActivity
| Description | Magnesium sulphate is currently the anticonvulsant of choice for the prevention and control of eclamptic fits. Magnesium sulfate is also widely used as a tocolytic agent[1][2]. |
|---|
| Related Catalog | Research Areas >>Cardiovascular DiseaseSignaling Pathways >>Others >>Others |
|---|
| References | [1]. Okusanya BO, et al. Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia. BJOG. 2016;123(3):356-366. [2]. Ramsey PS, et al. Magnesium sulfate as a tocolytic agent. Semin Perinatol. 2001;25(4):236-247. |
|---|
Chemical & Physical Properties
| Density | 1.07 g/mL at 20 °C |
|---|
| Boiling Point | 330ºC at 760 mmHg |
|---|
| Melting Point | 1124 °C |
|---|
| Molecular Formula | MgO4S |
|---|
| Molecular Weight | 120.368 |
|---|
| Exact Mass | 119.936768 |
|---|
| PSA | 88.64000 |
|---|
| Vapour density | <0.01 (vs air) |
|---|
| Vapour Pressure | <0.1 mm Hg ( 20 °C) |
|---|
| InChIKey | CSNNHWWHGAXBCP-UHFFFAOYSA-L |
|---|
| SMILES | O=S(=O)([O-])[O-].[Mg+2] |
|---|
| Stability | Stable. Hygroscopic. |
|---|
| Water Solubility | H2O: 1 M at 20 °C, clear, colorless |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- OM4500000
- CAS REGISTRY NUMBER :
- 7487-88-9
- LAST UPDATED :
- 199710
- DATA ITEMS CITED :
- 25
- MOLECULAR FORMULA :
- O4-S.Mg
- MOLECULAR WEIGHT :
- 120.37
- WISWESSER LINE NOTATION :
- MG S-O4
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - man
- DOSE/DURATION :
- 428 mg/kg
- TOXIC EFFECTS :
- Behavioral - muscle weakness Lungs, Thorax, or Respiration - other changes
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - woman
- DOSE/DURATION :
- 351 mg/kg
- TOXIC EFFECTS :
- Behavioral - muscle weakness Cardiac - arrhythmias (including changes in conduction) Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Human - woman
- DOSE/DURATION :
- 80 mg/kg/2M-I
- TOXIC EFFECTS :
- Cardiac - other changes Lungs, Thorax, or Respiration - cyanosis
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraspinal
- SPECIES OBSERVED :
- Human - woman
- DOSE/DURATION :
- 20 mg/kg
- TOXIC EFFECTS :
- Peripheral Nerve and Sensation - flaccid paralysis with appropriate anesthesia
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 1200 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 5 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 1029 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 645 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 48 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 1200 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 1500 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Mammal - cat
- DOSE/DURATION :
- 1 gm/kg
- TOXIC EFFECTS :
- Behavioral - general anesthetic
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rabbit
- DOSE/DURATION :
- 3 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rabbit
- DOSE/DURATION :
- 1750 mg/kg
- TOXIC EFFECTS :
- Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - other changes
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - guinea pig
- DOSE/DURATION :
- 1800 mg/kg
- TOXIC EFFECTS :
- Behavioral - general anesthetic Behavioral - somnolence (general depressed activity)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intravenous
- DOSE :
- 320 mg/kg
- SEX/DURATION :
- female 39 week(s) after conception
- TOXIC EFFECTS :
- Reproductive - Maternal Effects - other effects Reproductive - Effects on Embryo or Fetus - other effects to embryo
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 750 mg/kg
- SEX/DURATION :
- female 17-21 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - other effects to embryo Reproductive - Specific Developmental Abnormalities - hepatobiliary system
MUTATION DATA - TYPE OF TEST :
- Phage inhibition capacity
- TEST SYSTEM :
- Bacteria - Escherichia coli
- DOSE/DURATION :
- 800 umol/L
- REFERENCE :
- ENMUDM Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. Volume(issue)/page/year: 6,59,1984 *** U.S. STANDARDS AND REGULATIONS *** EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION FEREAC Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- Volume(issue)/page/year: 54,7740,1989 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 43410 No. of Facilities: 11060 (estimated) No. of Industries: 88 No. of Occupations: 80 No. of Employees: 106080 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 43410 No. of Facilities: 13961 (estimated) No. of Industries: 111 No. of Occupations: 95 No. of Employees: 235005 (estimated) No. of Female Employees: 108074 (estimated)
|
Safety Information
| Personal Protective Equipment | Eyeshields;Gloves;half-mask respirator (US);multi-purpose combination respirator cartridge (US) |
|---|
| Hazard Codes | Xi: Irritant; |
|---|
| Risk Phrases | R36/37/38 |
|---|
| Safety Phrases | S22-S24/25 |
|---|
| RIDADR | NONH for all modes of transport |
|---|
| WGK Germany | 1 |
|---|
| RTECS | OM4500000 |
|---|
| HS Code | 2833210000 |
|---|
Customs
Articles886
More Articles
| Transplantation of enteric neural stem/progenitor cells into the irradiated young mouse hippocampus. Cell. Transplant. 23(12) , 1657-71, (2015) Radiotherapy is an effective treatment for brain tumors but often results in cognitive deficits in survivors. Transplantation of embryonic or brain-derived neural stem/progenitor cells (BNSPCs) amelio... | |
| A synthetic O2 -tolerant butanol pathway exploiting native fatty acid biosynthesis in Escherichia coli. Biotechnol. Bioeng. 112(1) , 120-8, (2014) Several synthetic metabolic pathways for butanol synthesis have been reported in Escherichia coli by modification of the native CoA-dependent pathway from selected Clostridium species. These pathways ... | |
| Ultrastructural morphologic changes in mycobacterial biofilm in different extreme condition. Ultrastruct. Pathol. 39(1) , 38-48, (2015) The aim of this study was to investigate the morphologic and ultrastructural features of biofilms of slow and fast-growing mycobacteria in different stress conditions, presence and absence of oleic ac... | |
Synonyms
| Sal amarum |
| Salts |
| Magnesium sulfate |
| SULFURIC ACID, MAGNESIUM SALT |
| magnezium sulfate |
| salangalis |
| Sulfuric acid magnesium salt (VAN) |
| Sal anglicum |
| Dried |
| MFCD00011110 |
| saldesedlitz |
| Sulfate, Magnesium |
| EINECS 231-298-2 |
| Sulfuric acid, magnesium salt (1:1) |
| anhydrous magnesium sulphate |
| magnesium sulphate |
| MgSO4 |
| Hair salt |
| magnesium(II) sulfate |
| DBO2 |